Tag: Bcell
Mustang Bio Announces Updated Interim Phase 1/2 Data for MB-106 CD20-Targeted...
Data presented at the European Hematology Association 2021 Virtual Congress show favorable safety profile and compelling clinical activity 93% overall response rate...